Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
880

Quick answer

880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7767677

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7767784

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7767717

    Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

    Northwestern University · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7767816

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7771732

    Polymer network compositions and associated methods

    The Board of Regents of the University of Texas System · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7771963

    Methods for determining efficacy of chemotherapeutic agents

    Precision Therapeutics, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7772188

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7772370

    Antifungal polypeptides

    The Regents of the University of California · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7772387

    Oligonucleotides comprising a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7772219

    Methods of hormonal treatment utilizing extended cycle contraceptive regimens

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7772200

    iRNA agents targeted to the Rho-A gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7772366

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7772192

    Compositions and methods for treatment of disease with acetylated disaccharides

    The Regents of the University of California · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7772239

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7772250

    Compounds

    Theravance, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7772230

    Chroman compound, processes for its preparation, and its pharmaceutical use

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7772259

    1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7771707

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7772434

    Crystalline form of a β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7771956

    Method for detecting the presence of a phospholipid

    The United States of America—Department of Veterans Affairs · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7772271

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7771715

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7776365

    Article with skin protecting and moisturizing compound

    Sakura Properties, LLC · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7776521

    Coronavirus isolated from humans

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7776816

    Preserving hypoxic tissue

    The Board of Regents of the University of Texas System · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7776548

    Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues

    The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7776564

    Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use

    Five Prime Therapeutics, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7776593

    Hes6 as a marker of pancreatic endocrine cells

    The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7777027

    Purified beta glucan composition

    Immudyne, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7776905

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7777034

    Crystalline ammonium salts of rosuvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7777047

    Indole compound

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7777069

    Prodrugs of carbamate inhibitors of IMPDH

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7776537

    Method of preparing a PRRS virus vaccine

    Regents of the University of Minnesota · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7776320

    Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex

    The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7776823

    Human cathelicidin antimicrobial peptides

    The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7777000

    Anti-viral activity of cathelicidin peptides

    The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7777019

    Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7777036

    Heterocyclic derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7777077

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7776908

    Wortmannin analogs and methods of using same

    THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7776827

    Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome

    ImmuneRegen Biosciences, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7776879

    Quinuclidine carbamate derivatives and their use as M3 antagonists

    Almirall, S.A. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7776887

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7776847

    Benzisothiazoles useful for treating or preventing HCV infection

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7776337

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

880 published patents in our USPTO index have expiration dates falling in calendar year 2030.